BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26993317)

  • 1. PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis.
    Chen BB; Tien YW; Chang MC; Cheng MF; Chang YT; Wu CH; Chen XJ; Kuo TC; Yang SH; Shih IL; Lai HS; Shih TT
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1753-64. PubMed ID: 26993317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of
    Yu CW; Chen XJ; Lin YH; Tseng YH; Lu CC; Chen BB; Wei SY; Lee JM; Shih TT
    Eur J Radiol; 2019 Nov; 120():108671. PubMed ID: 31629121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer.
    Chen BB; Tien YW; Chang MC; Cheng MF; Chang YT; Yang SH; Wu CH; Kuo TC; Shih IL; Yen RF; Shih TT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1205-1217. PubMed ID: 29476229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival.
    Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Chang YH; Cheng MF; Shih TT
    J Magn Reson Imaging; 2021 Jan; 53(1):305-318. PubMed ID: 32798280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors.
    Shih IL; Yen RF; Chen CA; Chen BB; Wei SY; Chang WC; Sheu BC; Cheng WF; Tseng YH; Chen XJ; Chen CH; Wei LH; Chiang YC; Torng PL; Yen ML; Shih TT
    J Magn Reson Imaging; 2015 Dec; 42(6):1723-32. PubMed ID: 25919115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
    Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
    Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
    Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/MRI in Endometrial Cancer: Imaging Biomarkers are Associated with Disease Progression and Overall Survival.
    Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Zheng QY; Cheng MF; Chen JL; Shih TT
    Acad Radiol; 2024 Mar; 31(3):939-950. PubMed ID: 37714718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Volumetric Parameters in
    Tseng JR; Yang LY; Lin YC; Liu CY; Pang ST; Hong JH; Yen TC; Wang LJ
    Contrast Media Mol Imaging; 2018; 2018():8945130. PubMed ID: 30532664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
    Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
    BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
    Ohno Y; Koyama H; Yoshikawa T; Nishio M; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Maniwa Y; Nishio W; Nishimura Y; Itoh T; Sugimura K
    Radiology; 2011 Nov; 261(2):605-15. PubMed ID: 21926377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
    Tsuchida T; Morikawa M; Demura Y; Umeda Y; Okazawa H; Kimura H
    J Magn Reson Imaging; 2013 Jul; 38(1):80-8. PubMed ID: 23239463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between apparent diffusion coefficients and metabolic parameters in hypopharyngeal squamous cell carcinoma: A prospective study with integrated PET/MRI.
    Zhang L; Song T; Meng Z; Huang C; Chen X; Lu J; Xian J
    Eur J Radiol; 2020 Aug; 129():109070. PubMed ID: 32454330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
    Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.